"El Centro Médico y de Investigación Orlandi Oncología, trabaja en distintas etapas de tratamiento con pacientes oncológicos, brindando orientación y diagnóstico, entregando terapias innovadoras contra el cáncer, contando con el seguimiento de los pacientes, llevado a cabo por nuestros especialistas."

During the past decade, Orlandi Oncologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Orlandi Oncologia" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Mesothelioma" (1 trials). Many other conditions were trialed in "Orlandi Oncologia" in a lesser frequency.

Most popular intervention types in "Orlandi Oncologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (1 trials), "Nintedanib" (1 trials), "Pemetrexed" (1 trials), "Placebo" (1 trials) and "afatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orlandi Oncologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Orlandi Oncologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Orlandi Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Orlandi Oncologia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".